A NEW study has linked the rising cases of malaria in most parts of sub-Saharan Africa to construction and sitting of dams as well as flooding.

Cases of malaria and dengue have fallen in 2015 compared to 2014, according to a report submitted by the Kolkata Municipal Corporation (KMC) to the director of National Vector Borne Control Program

Malaria scare has gripped Mewat as more than 35 deaths have been reported in the district in one-and-a-half months. Punhana block is the worst hit.

Artemisinin-based combination therapies (ACTs) are the recommended first-line treatment for uncomplicated Plasmodium falciparum malaria. Ferroquine is a new combination partner for fast-acting ACTs such as artesunate. We aimed to assess different doses of ferroquine in combination with artesunate against uncomplicated P falciparum malaria in a heterogeneous population in Africa.

The RTS,S/AS01 malaria vaccine targets the circumsporozoite protein, inducing antibodies associated with the prevention of Plasmodium falciparum infection. We assessed the association between anti-circumsporozoite antibody titres and the magnitude and duration of vaccine efficacy using data from a phase 3 trial done between 2009 and 2014. Using data from 8922 African children aged 5–17 months and 6537 African infants aged 6–12 weeks at first vaccination, we analysed the determinants of immunogenicity after RTS,S/AS01 vaccination with or without a booster dose.

A survey conducted by the district malaria authorities from August 19 to 30 has found the dengue larvae breeding in over 16,000 spots in the city.

As Delhi and other parts of the country battle the surge in dengue cases, here is a look at how vector-borne diseases have been spreading their tentacles over the years.

As many as 6700 water samples have failed out of the total 21265 water samples taken from water tanks at bus stands, schools, colleges and public places under the cleanliness campaign being carried

Women in Kenya are enjoying a higher life expectancy than men, living to an average of 67.5 years compared to 63 for men.

A new anti-malaria vaccine called Mosquirix was recently approved by the European drugs regulators.

Pages